MECHANISMS & TREATMENT OF PROGRESSIVE DAMAGE AFTER TBI

机制

• 批准号: 6650410
• 负责人: Helen M Bramlett
• 金额: $ 22.19万
• 依托单位: UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2002
• 资助国家: 美国
• 起止时间: 2002-07-19 至 2007-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6650410
• 关键词: atrophy; brain injury; cellular pathology; histopathology; immunocytochemistry; laboratory rat; magnetic resonance imaging; nerve injury; neuropathology; neuropharmacologic agent; neuropharmacology; neuropsychological tests; neuropsychology; neurotoxicology; pathologic process; periaqueductal gray matter; protein structure; trauma

Several laboratories using focal and diffuse models of traumatic brain injury (TBI) have reported the progressive nature of histopathological damage that can continue in rodent models up to one year. Evidence for progressive damage has previously been reported in humans following head trauma. Preliminary data in this application presented for the first time provides quantitative data for chronic white matter pathology following moderate fluid-percussion brain injury. The overall goal of the proposed studies is to assess the importance of moderate and severe TBI on long-term vulnerability patterns after trauma. In Specific Aim 1, regional patterns of gray and white matter pathology and their associated neurobehavioral alterations will be assessed. Histopathological techniques along with magnetic resonance imaging (MRI) strategies will be used to assess temporal and regional patterns of progressive damage in order to correlate these changes with behavioral outcomes. In Specific Aim 2, immunocytochemical markers of axonal damage, demyelination, cell atrophy, and cell death will be utilized to assess cellular injury progression. To begin to determine the pathomechanisms underlying progressive white matter injury, the role of prolonged hypoperfusion and abnormal protein aggregation on these structural changes will be regionally and temporally assessed. Finally, therapeutic strategies targeting excitotoxic processes as well as abnormal protein aggregation will be evaluated to reduce progression of advancing atrophy. It is felt that these experiments are necessary to understand the pathogenesis of progressive injury as well as to develop therapeutic strategies to promote recovery of function following TBI. Established animal models and behavioral, MRI, immunocytochemical, autoradiography, and molecular techniques will be utilized.

使用创伤性脑损伤（TBI）的局灶性和弥漫模型的几个实验室报告了组织病理学损害的进行性性质，这些性质可能会在啮齿动物模型中持续一年。头部创伤后人类已经报道了进行性损害的证据。该应用程序中首次提出的本应用中的初步数据为慢性白质病理学提供了定量数据。拟议研究的总体目标是评估中等和重度TBI在创伤后长期脆弱模式的重要性。在特定的目标1中，将评估灰质和白质病理的区域模式及其相关的神经行为改变。组织病理学技术以及磁共振成像（MRI）策略将用于评估渐进损伤的时间和区域模式，以将这些变化与行为结果相关联。在特定的目标2中，将利用轴突损伤，脱髓鞘，细胞萎缩和细胞死亡的免疫细胞化学标记来评估细胞损伤的进展。为了开始确定渐进性白质损伤的病理机制，将在区域和时间上评估这些结构变化的长期灌注和异常蛋白质聚集的作用。最后，将评估针对兴奋性过程以及异常蛋白质聚集的治疗策略，以减少促进萎缩的进展。人们认为，这些实验对于了解进行性损伤的发病机理以及制定治疗策略以促进TBI后功能的恢复。建立的动物模型和行为，MRI，免疫细胞化学，放射自显影和分子技术将被利用。